Pharmacy Plus, Inc. dba Vital Care Compounder: Drug Recall

Recall #D-0538-2023 · 04/13/2023

Class II: Risk

Recall Details

Recall Number: D-0538-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Pharmacy Plus, Inc. dba Vital Care Compounder
Status: Ongoing
Date Initiated: 04/13/2023
Location: Hattiesburg, MS, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 45 vials

Reason for Recall

Lack of assurance of sterility.

Product Description

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Distribution Pattern

MS only

Other Recalls by Pharmacy Plus, Inc. dba Vital Care Compounder

Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

View all recalls by Pharmacy Plus, Inc. dba Vital Care Compounder →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.